Occuity inks European partnerships for handheld ophthalmic device

DISCLOSURE: Longevity.Technology (a brand of First Longevity Limited) has been contracted by the company featured in this article to support its current funding round. Qualifying investors can find out more via the Longevity.Technology investment portal.

British MedTech company Occuity announced several European distributor partnerships ahead of the upcoming launch of its PM1 Pachymeter. The company has developed the world’s only non-contact, handheld optical pachymeter, which supports glaucoma diagnosis by measuring corneal thickness in just a few seconds.

“We are looking forward to introducing the PM1 to the market. Having completed successful clinical trials and submitted for CE certification, we are confident in its exceptional performance,” said Dan Daly, CEO of Occuity. “Through discussions with distributors across Europe, we believe there will be significant demand for the PM1 and have therefore carefully chosen partners who share our dedication to delivering exceptional ophthalmic devices.”

In the UK, Occuity has partnered with Birmingham Optical, a respected distributor known for its commitment to quality products and lasting partnerships.

“We are thrilled to partner with Occuity and be part of introducing the PM1 to the UK market,” said Amanda Higginbotham, Chief Commercial Officer at Birmingham Optical. “With their non-contact, handheld platform, Occuity have an exciting pipeline of future products including the AX1 Axiometer for Myopia Management, and we look forward to working with them.”

The company has also signed distributor agreements with renowned ophthalmic companies in various European countries, including E. Janach in Italy, bon Optic in Germany, Medilens for the Nordic countries, and Iogen Oy for Finland, Latvia, and Estonia.

“Occuity has delivered an excellent product with clear advantages of existing options,” said Antonello Spinnato, Global Managing Director at E. Janach. “We believe that the PM1 Pachymeter has the potential to become the primary method of measuring central corneal thickness and are excited to offer this ground-breaking technology to our customers.”

Occuity is also in discussions with distributors to cover APAC and North American territories.